South Korea’s biotechnology firm Seegene (KQ096530) said Monday it developed the world’s first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
Herewith we would like to inform you that all three Seegene COVID-19 kits (Cat. # RP10243X; RV10248X; RV10259X) are capable of detecting the new UK and South Africa variant of SARS-CoV-2.
At their virtual booth, Seegene presented their complete solution for COIVD-19 diagnostics including new videos
Herewith we would like to inform you that the Extraction-Free application of the Seegene Allplex™ SARS-CoV-2 Assay is now also available.
Social Links